What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?

References

• Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol 2012; 50:911–1164.
   PubMed Web of Science ®Google Scholar
• Khan LR, Oniscu GC, Powell JJ. Long-term outcome following liver transplantation for paracetamol overdose. Transpl Int 2010; 23:524–529.
   PubMed Web of Science ®Google Scholar
• Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J; Toxicology Investigators Consortium Case Registry Investigators. The Toxicology Investigators Consortium Case Registry-The 2011 Experience. J Med Toxicol 2012; 8:360–377.
   PubMedGoogle Scholar
• James LP, Chiew A, Abdel-Rahman SM, Letzig L, Graudins A, Day P, Roberts D. Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate- release vs extended-release formulations. Eur J Clin Pharmacol 2013; 69:851–857.
   PubMed Web of Science ®Google Scholar
• Duewall JL, Fenves AZ, Richey DS, Tran LD, Emmett M. 5-oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use. Proc (Bayl Univ Med Cent) 2010; 23:19–20.
   PubMedGoogle Scholar
• Croal BL, Glen AC, Kelly CJ, Logan RW. Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem 1998; 44:336–340.
   PubMed Web of Science ®Google Scholar
• Tailor P, Raman T, Garganta CL, Njalsson R, Carlsson K, Ristoff E, Carey HB. Recurrent HAGMA secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis 2005; 46:e4–10.
   PubMed Web of Science ®Google Scholar
• Rolleman EJ, Hoorn EJ, Didden P, Zietse R. Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis. Neth J Med 2008; 66:351–353.
   PubMed Web of Science ®Google Scholar
• Bonham JR, Rattenbury JM, Meeks A, Pollitt RJ. Pyroglutamic aciduria from vigabatrin. Lancet 1989; 1:1452–1453.
   PubMedGoogle Scholar
• Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med 1999; 33:452–456.
   PubMed Web of Science ®Google Scholar
• Gray TA, Buckley BM, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol overdose. Q J Med 1987; 65: 811–821.
   PubMedGoogle Scholar
• Green TJ, Bijlsma JJ, Sweet DD. Profound metabolic acidosis from pyroglutamic acidemia: an underappreciated cause of HAGMA. CJEM 2010; 12:449–452.
   PubMedGoogle Scholar
• Reddi AS, Kunadi AR. Recurrent anion gap metabolic acidosis in a woman with vertebral disc disease. Am J Emerg Med 2011; 29:962.
   PubMedGoogle Scholar
• Yale SH, Mazza JJ. Anion gap acidosis associated with acetaminophen. Ann Intern Med 2000; 133:752–753.
   PubMed Web of Science ®Google Scholar
• Hodgman MJ, Horn JF, Stork CM, Marraffa JM, Holland MG, Cantor R, Carmel PM. Profound metabolic acidosis and oxoprolinuria in an adult. Med Toxicol 2007; 3:119–124.
   Google Scholar
• Howie S, Tarn A, Soper C. A not so simple analgesic. NDT Plus 2010; 3:573–575.
   PubMedGoogle Scholar
• Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM. Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation. Am J Med Sci 2012; 344:501–504.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Forman JP, Zandi-Nejad K, Bazari H, Seifter J, Magee CC. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis 2005; 46:143–146.
   PubMed Web of Science ®Google Scholar
• Romero JE, Htyte N. An unusual cause of high anion gap metabolic acidosis: pyroglutamic acidemia. A case report. Am J Ther 2011.
   Google Scholar
• Myall K, Sidney J, Marsh A. Mind the gap! An unusual metabolic acidosis. Lancet 2011; 377:526.
   PubMed Web of Science ®Google Scholar
• O’Brien LM, Hooper M, Flemmer M, Marik PE. Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon. BMJ Case Rep 2012; 2012.
   Google Scholar
• Foot CL, Fraser JF, Mullany DV. Pyroglutamic acidosis in a renal transplant patient. Nephrol Dial Transplant 2005; 20:2836–2838.
   PubMed Web of Science ®Google Scholar
• Prasad, S. A case of high anion gap metabolic acidosis: what's the anion? (abstract) Crit Care Med 2012; 40:298.
   Google Scholar
• Creer MH, Lau BW, Jones JD, Chan KM. Pyroglutamic acidemia in an adult patient. Clin Chem 1989; 35:684–686.
   PubMed Web of Science ®Google Scholar
• Fenves AZ, Kirkpatrick HM III, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 2006; 1:441–447.
   PubMed Web of Science ®Google Scholar
• Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med 2000; 28:1803–1807.
   PubMed Web of Science ®Google Scholar
• Leung PSC, Tsui SH, Siu TS, Tam S. Acquired 5-oxoprolinuria (Pyroglutamic acidaemia) as a cause of early high anion gap metabolic acidosis in acute massive paracetamol overdose. Hong Kong JEmerg Med 2011; 18:264–270.
   Web of Science ®Google Scholar
• Alados Arboledas FJ, de la Olivia Senovilla P, Garcia Muñoz MJ, Alonso Melgar A, Ruza Tarrío F. Acidosis piroglutámica asociada a paracetamol. An Pediatr (Barc) 2007; 67:582–584.
   PubMedGoogle Scholar
• Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem 1998; 44:1497–1503.
   PubMed Web of Science ®Google Scholar
• Pitt JJ, Brown GK, Clift V, Christodoulou J. Atypical pyroglutamic aciduria: possible role of paracetamol. J Inherit Metab Dis 1990; 13:755–756.
   PubMed Web of Science ®Google Scholar
• Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL. An unusual cause of severe metabolic acidosis. Med J Aust 2006; 185:223–225.
   PubMed Web of Science ®Google Scholar
• Armenian P, Gerona RR, Blanc PD, Wu AH, Mookherjee S. 5-oxoprolinemia causing elevated anion gap metabolic acidosis in the setting of acetaminophen use. J Emerg Med 2012; 43:54–57.
   PubMed Web of Science ®Google Scholar
• Kortmann W, van Agtmael MA, van Diessen J, Kanen BL, Jakobs C, Nanayakkara PW. 5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. Neth J Med 2008; 66:354–357.
   PubMed Web of Science ®Google Scholar
• Milosevic S, Tran K, O’Brien B. A rare cause of high anion gap metabolic acidosis. Intern Med J 2013; 43:100–101.
   PubMed Web of Science ®Google Scholar
• Chestnutt J, Heyburn G, Roberts B. Pyroglutamic aciduria: a cause of high anion-gap metabolic acidosis associated with common drugs. Ir Med J 2011; 104:312–313.
   PubMedGoogle Scholar
• Ristoff E, Larsson A. Patients with genetic defects in the gamma- glutamyl cycle. Chem Biol Interact 1998; 111–112:113–121.
   PubMed Web of Science ®Google Scholar
• Mistry D, Stockley RA. Gamma-glutamyl transferase: the silent partner?COPD 2010; 7:285–290.
   PubMedGoogle Scholar
• Almaghlouth IA, Mohamed JY, Al-Amoudi M, Al-Ahaidib L, Al-Odaib A, Alkuraya FS. 5-Oxoprolinase deficiency: report of the first human OPLAH mutation. Clin Genet 2012; 82:193–196.
   PubMed Web of Science ®Google Scholar
• Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2007; 2:16.
   PubMed Web of Science ®Google Scholar
• Amer H, Dockery F, Barrett N, George M, Witek K, Stanton J, Back D. Refractory metabolic acidosis in patients with sepsis following hemiarthroplasty for femoral neck fracture: a causative role for paracetamol and flucloxacillin? BMJ Case Rep 2011; pii: bcr0520114292.
   Google Scholar
• Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R. High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem 2007; 44:406–409.
   PubMed Web of Science ®Google Scholar
• Holman M, ter Maaten JC. [Severe metabolic acidosis as a result of 5-oxoproline in acetaminophen use]. Ned Tijdschr Geneeskd 2010; 154:A1838. [Article in Dutch]
   PubMedGoogle Scholar
• Lawrence DT, Bechtel LK, Charlton NP, Holstege CP. 5-oxoproline-induced anion gap metabolic acidosis after an acute acetaminophen overdose. J Am Osteopath Assoc 2010; 110:545–551.
   PubMedGoogle Scholar
• Verma R, Polsani KR, Wilt J, Loehrke ME. 5-Oxoprolinuria as a cause of high anion gap metabolic acidosis. Br J Clin Pharmacol 2012; 73:489–491.
   PubMed Web of Science ®Google Scholar
• Zein JG, Wallace DJ, Kinasewitz G, Toubia N, Kakoulas C. Early anion gap metabolic acidosis in acetaminophen overdose. Am J Emerg Med 2010; 28:798–802.
   PubMed Web of Science ®Google Scholar
• Tokatli A, Kalkanoğlu-Sivri HS, Yüce A, Coşkun T. Acetaminophen induced hepatotoxicity in a glutathione synthetase-deficient patient. Turk J Pediatr 2007; 49:75–76.
   PubMed Web of Science ®Google Scholar
• Njålsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S. Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 2005; 116:384–389.
   PubMed Web of Science ®Google Scholar
• Sathiyathasan S, Jeyanthan K, Hamid R. Metabolic acidosis in late pregnancy due to 5-oxoproline (pyroglutamic acid)—A case report. Open J Obstetr Gynecol 2012; 2:170–173.
   Google Scholar